Has Meriner Pereira, MD received payments from drug or device companies?

Yes. Drug and device makers reported $799 in general payments to Meriner Pereira, MD across 32 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Meriner Pereira, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Meriner Pereira, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Meriner Pereira, MD

Dermatology · Muscatine, IANPI 1639226731

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Janssen Scientific Affairs, LLC at 31.3% of the total. That places this record below the midpoint for dermatology clinicians in IA, where the typical reported total is $716.

$799in general payments, 2019–2025

Across 32 payments — averaging $24.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Scientific Affairs, LLC$250
UCB, Inc.$94
AbbVie$93
Lilly USA, LLC$81
Novartis$65
Galderma Laboratories, L.p.$52
plus $164 from 8 others

What the payments were for

Food & beverage$799100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Scientific Affairs, LLC	2	$250
UCB, Inc.	4	$94
AbbVie(2 entities)	5	$93
Lilly USA, LLC	4	$81
Novartis	3	$65
Galderma Laboratories, L.p.	3	$52
Sanofi	3	$47
Regeneron Healthcare Solutions, Inc.	1	$25
Johnson & Johnson	1	$18
E.r. Squibb & Sons, L.L.C.	1	$16
Organon	2	$16
Pfizer	1	$15
Boehringer Ingelheim	1	$14
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$250

How this compares

$799 in reported general payments places this provider in the 50th percentile of 92 dermatology providers in Iowa.

See all dermatology providers in Iowa →

Medicare billing

Part B allowed, 2024

$474,570

Medicare patients

1,572

Services billed

6,997

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab	22	$282,954
Humira(Cf) PenAdalimumab	25	$203,045
Taltz AutoinjectorIxekizumab	22	$188,555
Cosentyx Sensoready PenSecukinumab	12	$182,809
Dupixent PenDupilumab	39	$160,585
OtezlaApremilast	30	$150,796
Cosentyx Unoready PenSecukinumab	14	$147,025
Dupixent SyringeDupilumab	14	$54,620
Fluocinonide	88	$6,091
Ketoconazole	333	$5,420
Clobetasol Propionate	111	$4,154
Betamethasone Dipropionate	60	$3,861
Betamethasone Valerate	91	$3,236
Triamcinolone Acetonide	301	$2,904
Calcipotriene	19	$2,634

Paid to pharmacies, not to this prescriber.

Other dermatology in Muscatine

Roger CeilleyWest Des Moines$82K
David KnutsonCedar Rapids$60K
Scott GreenFort Dodge$56K
Timothy AbrahamsonUrbandale$49K
Ali JabbariIowa City$38K
Ravindrakumar GangadhariahDavenport$20K
Somaira NowsheenWaukee$15K
Laura MyersAnkeny$7K
Katrina SmithAnkeny$7K
Kirsten DickinsonClive$6K

See the full list for Iowa →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →